Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015

Background: Herpes zoster (HZ), or shingles, is caused by reactivation of varicella-zoster virus in latently infected individuals. Live-attenuated HZ vaccine (zoster vaccine live, ZVL) is approved in the United States for persons aged ≥50 years and recommended by the CDC for persons ≥60 years. Metho...

Full description

Bibliographic Details
Main Authors: Elaine R. Miller, Paige Lewis, Tom T. Shimabukuro, John Su, Pedro Moro, Emily Jane Woo, Christopher Jankosky, Maria Cano
Format: Article
Language:English
Published: Taylor & Francis Group 2018-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
adverse event
herpes zoster
immunization
shingles
vaccine adverse event reporting system (vaers)
vaccine safety
vaccine
varicella
Online Access:http://dx.doi.org/10.1080/21645515.2018.1456598

Internet

http://dx.doi.org/10.1080/21645515.2018.1456598

Similar Items